Evidence map›Paper›PMID 42668821›Full record

ArticleCureus2026

Two Cases of Intentional Sodium Nitrite Poisoning With Contrasting Outcomes: The Critical Role of Early Recognition and Treatment.

Kinga Lichtarska, Sviatlana Filitaryna, Monika Wiatr, Magda Marciniak, Michał Gutowski, Monika Kałwak, Aleksandra Foryś, Wojciech Wojas, Cezary Orzechowski, Justyna Żabicka and 1 more

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kinga LichtarskaDepartment of Internal Medicine, St. Elizabeth's Hospital, LUX MED Group, Warsaw, POL.
Sviatlana FilitarynaDepartment of Internal Medicine, Dr. Tytus Chałubiński Specialist Hospital, Radom, POL.
Monika WiatrDepartment of Internal Medicine, Dr. Tytus Chałubiński Specialist Hospital, Radom, POL.
Magda MarciniakDepartment of Internal Medicine, Dr. Tytus Chałubiński Specialist Hospital, Radom, POL.
Michał GutowskiDepartment of Medicine, Medical University of Warsaw, Warsaw, POL.
Monika KałwakDepartment of Internal Medicine, Independent Public Health Care Facility of the Ministry of the Interior and Administration named after Sergeant Grzegorz Załoga, Katowice, POL.
Aleksandra ForyśDepartment of Internal Medicine, St. Barbara Provincial Specialist Hospital No. 5, Sosnowiec, POL.
Wojciech WojasDepartment of Medicine, Maria Skłodowska-Curie Medical Academy, Warsaw, POL.
Cezary OrzechowskiDepartment of Medicine, Medical University of Warsaw, Warsaw, POL.
Justyna ŻabickaDepartment of Medicine, Maria Skłodowska-Curie Medical Academy, Warsaw, POL.
Patryk DłubisDepartment of Internal Medicine, Municipal Hospital in Gliwice, Gliwice, POL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intentional sodium nitrite poisoning may result in severe methemoglobinemia and life-threatening tissue hypoxia. We present two cases of intentional sodium nitrite ingestion with markedly different clinical outcomes, both managed at the same center and treated with methylene blue at different stages of clinical deterioration, thereby illustrating the potential importance of early recognition and treatment timing. The first patient was a 31-year-old man without a significant medical history who was found unconscious in his apartment after an unknown interval following ingestion; therefore, the time to emergency medical intervention could not be determined. He remained in cardiac arrest upon admission, with ongoing advanced life support, mechanical ventilation, and mechanical chest compressions. Methylene blue was administered intravenously immediately upon admission to the Toxicology Unit in two doses of 2 mg/kg (170 mg each) given 15 minutes apart, corresponding to a total cumulative dose of 4 mg/kg (340 mg). Initial laboratory investigations revealed an extremely high methemoglobin level of 97% (typical reference value: <2%), profound acidosis (pH 6.684), severe hyperlactatemia (29 mmol/L), and critically impaired oxygenation. Return of spontaneous circulation was not achieved, and the patient was pronounced dead 40 minutes after admission to the Toxicology Unit. The second patient was a 22-year-old woman with a history of personality disorder who ingested 7.5 g of sodium nitrite and promptly informed her family, enabling rapid activation of Emergency Medical Services (EMS). Methylene blue was administered intravenously approximately 50 minutes after ingestion in two doses of 2 mg/kg (160 mg each) given 15 minutes apart, corresponding to a total cumulative dose of 4 mg/kg (320 mg). Her initial methemoglobin concentration was 66.1%, and antidotal treatment resulted in rapid clinical and laboratory improvement. Despite requiring prolonged intensive care and treatment for pneumonia, she was discharged after 22 days without neurological sequelae. These cases highlight the critical importance of early recognition and prompt initiation of antidotal therapy in sodium nitrite poisoning. The markedly different outcomes observed in two patients exposed to the same toxic agent suggest that prolonged untreated tissue hypoxia may have a greater influence on prognosis than the absolute methemoglobin concentration alone. Although no firm conclusions can be drawn from two cases, the findings suggest that early methylene blue administration combined with intensive supportive care may be associated with favorable outcomes even in severe poisoning.

Indexed as

antidotecase reportemergency medicineintensive caremethemoglobinemiamethylene bluepoisoningsodium nitritesuicide attempttoxicology

Identifiers

PMID42668821
PMCPMC13525784

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.